Open Access 10.12.2020 | original article
Personal protective equipment in the COVID-19 pandemic and the use of cooling-wear as alleviator of thermal stress
A pilot study in plastic surgery staff members
Erschienen in: Wiener klinische Wochenschrift | Ausgabe 7-8/2021
High temperatures at workplaces lead to health-related risks and premature exhaustion. The coronavirus disease 2019 (COVID-19) pandemic requires many health professionals to perform under unfavorable conditions. Personal protective equipment (PPE) causes thermal stress and negatively affects performance.
Patients, materials and methods
This pilot project investigated the effects of PPE and additional cooling wear on physiological parameters and concentration of six healthy staff members of the Plastic Surgery Department of the Medical University of Graz, Austria during simulated patient care. In this study two 1‑hour cycles with patient care-related tasks with PPE and PPE + cooling-wear, respectively, were conducted. A third cycle with scrubs exclusively served as baseline/negative control. The assessment occurred immediately pre-cycles and post-cycles.
Pre-cycle assessments showed no significant differences between the cycles. After PPE cycle, increased physical stress levels and decrements in concentration capacity were observed. Physiological parameters were significantly less affected in the cooling cycle, while concentration capacity slightly increased.
COVID-19 PPE causes considerable thermal stress, ultimately affecting human performance. As opportunity to withstand thermal stress, and improve patients’ and professionals’ safety, cooling-wear can be considered relevant. Medical personnel performing in exceptional situations may particularly benefit from further development and investigation of cooling strategies.
All data generated or analyzed during this study are included in this published article (and its supplementary information files).
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Several professions require the performance in high-temperature scenarios leading to physical stress, ultimately affecting human performance . For instance, medical personnel in the care of patients suffering from potentially dangerous and infectious diseases need to use personal protective equipment (PPE) causing considerable discomfort . The novel severe acute respiratory syndrome-coronavirus‑2 (SARS-CoV-2) and the resulting coronavirus disease 2019 (COVID-19) pandemic have become a serious challenge regarding spread, treatment, and prevention . Involved caregivers need to work with impermeable PPE, consisting of FFP3 face masks, protective goggles, gloves and suits, to avoid contagion while ensuring proper medical care [4, 5]. Effective shielding is not only necessary for healthcare workers and patients, to maintain adequate healthcare but also the whole population by reducing further spreading of pathogens . Besides the morbidity among patients , SARS-CoV‑2 also mediates higher morbidity among medical staff . Not only psychological stress and anxiety  but also high temperatures resulting in thermal stress caused by PPE should be considered a major risk factor.
While physiological responses of the human organism to high temperatures have been well established, their impact on cognition and well-being is less clear ; yet, even relatively mild thermal stress may affect human performance [1, 8]. Considerable discomfort and medical negligence can be effects thereof , hence negatively influencing a patient’s care.
Only few studies have evaluated different PPEs or ways of donning and doffing . A significant heat strain has been shown with selectively permeable membranes . Considering that fluid-resistant and impermeable suits may protect better against contamination than aprons , people caring for COVID-19 patients suffer from the additional burden of significant thermal stress when using effective protection.
The use of cooling wear is one novel strategy using the principle of evaporation to reduce thermal stress in situations exposing professionals to high temperatures . While experiences with cooling wear in the medical field showed positive results in previous studies , the benefit of use in combination with PPE still needs to be determined. The primary aim of this project was to investigate the impact of PPE used in the treatment of COVID-19 patients on the human organism as well as the effect of additional cooling wear as a suitable coping strategy.
The study design and protocol were approved by the ethical review committee of the Medical University of Graz (EK: 1318/2019). Written informed consent was obtained from study participants prior to the study start.
In this study four female (age range: 27–40 years) and two male (range: 30–48 years) healthy, non-pregnant staff members of the Plastic Surgery Division of the University Hospital Graz, Austria, were enrolled.
The tested cooling wear QRCOOL was provided by QRSKIN GmbH (Würzburg, Germany) .
The study was conducted under constant regular room temperature (22 °C ± 0.5 °C) at the University Hospital Graz. The study consisted of three cycles that were performed within 2 days:
Cycle one (base cycle) served as a baseline. Subjects’ garment consisted of regular scrubs exclusively to determine effects of the tasks to perform.
Cycle two (PPE cycle) served to explore effects of PPE. Subjects’ garment consisted of scrubs plus PPE as used in the care of COVID-19 patients (suits: Tychem 2000 C Cat. III model CHA5, DuPont de Nemours, Wilmington, DE, USA, 180 μm thickness and model FH-190, Beijing Winsunny Harmony Science & Technology Co., Ltd., Beijing, China, 240 µm thickness).
Cycle three (cooling cycle) served to explore effects of PPE and additional cooling-wear. Subjects’ garment consisted of a cooling shirt/vest, which was worn on bare skin, plus scrubs and PPE.
Subjects were instructed about the process, completed a standardized d2‑R attention test , underwent thermal imaging of chest and upper back and had blood pressure (BP), heart rate (HR) and body temperature (BT) measured before each cycle. All assessments were performed with the garment of each respective cycle. Afterwards, subjects performed standardized tasks for 1h. A total of six tasks representing abilities needed in COVID-19 patient care, targeting mental capacity (e.g. logic-based puzzles), manual dexterity (e.g. surgical sewing) and strength (e.g. static strain) lasting 9 min each had to be completed by each subject. A rotation time of 1 min was determined between tasks. Fig. 6 in the Appendix depicts the schematic course of the activity cycles. After each cycle, subjects underwent the same assessment procedures again before having an adequate break. Subjects then proceeded to the second cycle undergoing the same procedure with scrubs and PPE. To rule out an effect of fatigue or familiarization, the third cycle (cooling cycle) was performed on the next day with the otherwise same set-up.
Thermal imaging was conducted with FLIR One® Pro for iOS (FLIR Systems, Wilsonville, OR, USA). Imaging material was processed via FLIR One® App . Within a region of interest (ROI, the human body), the average temperature was calculated.
The BT was measured with a contactless infrared forehead thermometer (Hetaida HTD8812, Shenzhen Hetaida Technology Co., Ltd., China).
Systolic and diastolic BP, and HR were measured with a noninvasive, fully automatic BP monitor (boso-medicus uno, BOSCH + SOHN GmbH u. Co. KG, Jungingen, Germany).
Concentration and attention were measured with the d2‑R test of attention, which is a reliable measure of attention based on normative samples . The total number of errors (TNE) and the concentration performance indicator (CPI) were calculated.
Data were analysed with GraphPad Prism software (version 8.0; GraphPad Software, Inc., San Diego, CA, USA). Due to the small sample size, testing for normality was omitted. Since the conditions for the parametric t‑test could not be guaranteed, group differences were assessed using the non-parametric Wilcoxon signed-rank test. Results are expressed as median (mdn) and interquartile range (Q1 and Q3). Mann-Whitney U‑test was used to determine significant differences between the two types of protective clothing. Results in means and standard deviations are summarized in Table 1 in the Appendix. All statistical tests were two-tailed with the alpha level set at p = 0.05.
A descriptive overview of all physiological parameters is provided in Fig. 1.
The BT of each subject was measured pre-cycle and post-cycle. Fig. 2 shows boxplots of the BT results.
Median BT before the base cycle was 36.40 °C (Q1: 35.93 °C; Q3: 36.45 °C). After completion it was 36.40 °C (Q1: 36.08 °C; Q3: 36.53 °C). No significant difference was observed (p = 0.875).
Median BT before the PPE cycle was 36.40 °C (Q1: 36.08 °C; Q3: 36.53 °C). It rose to 37.05 °C after the cycle. The difference before and after the cycle was significant (p = 0.031).
Median BT before the cooling cycle was 36.50 °C (Q1: 36.20 °C; Q3: 36.50 °C). After the cycle, it rose to 36.55 °C (Q1: 36.18 °C; Q3: 36.60 °C). The difference before and after the cycle was not significant (p = 0.500).
The pre-cycle assessment showed no significant difference in median BTs (p = 0.875). The difference after the two cycles was significant (p = 0.031).
The pre-cycle assessment showed no significant difference in median BTs (p = 0.156). The difference after these two cycles was not significant (p = 0.875).
The pre-cycle assessment showed no significant difference in median BTs (p > 0.999). The difference after these two cycles was significant (p = 0.031).
Two different protective suits were analyzed regarding their heat production potential. No significant difference could be shown in BT between the suits neither within nor between PPE (p = 0.500) and cooling cycle (p = 0.100).
Surface temperature (ST) of each subject was measured via FLIR One® Pro pre-cycle and post-cycle. Fig. 2 shows boxplots of the thermal imaging results. Cooling effects can be seen on chest and upper back after cooling cycle (see Fig. 3).
Median ST before base cycle was 23.85 °C (Q1: 22.28 °C; Q3: 25.00 °C). Afterwards, it was 24.00 °C (Q1: 22.05 °C; Q3: 24.60 °C). No significant difference was observed (p = 0.656).
Median ST before PPE cycle was 24.50 °C (Q1: 23.73 °C; Q3: 24.70 °C). Afterwards, it rose to 26.95 °C (Q1: 26.48 °C; Q3: 27.35 °C). The difference was significant (p = 0.031).
Median ST before cooling cycle was 24.50 °C (Q1: 24.05 °C; Q3: 24.95 °C). Afterwards, it rose to 26.00 °C (Q1: 25.55 °C; Q3: 26.25 °C), indicating a significant difference (p = 0.031).
Pre-cycle assessment showed no significant difference in median ST (p = 0.688). The difference thereafter was significant (p = 0.031).
Pre-cycle assessment showed no significant difference in median ST (p = 0.219). The difference after these cycles was significant (p = 0.031).
The pre-cycle assessment showed no significant difference in median ST (p = 0.188). The difference after these cycles was significant (p = 0.031).
The HR of each subject was measured pre-cycle and post-cycle. Fig. 4 shows boxplots of the heart rate results.
Median heart rate before the base cycle was 76.5 bpm (Q1: 68.3 bpm; Q3: 79.5 bpm) and 73.5 bpm (Q1: 66.5 bpm; Q3: 78.0 bpm) afterwards, yielding no significant difference (p = 0.063).
Median heart rate before the PPE cycle was 73.5 bpm (Q1: 66.5 bpm; Q3: 78.0 bpm), afterwards it rose to 88.0 bpm (Q1: 82.3 bpm; Q3: 92.0 bpm), yielding a significant difference (p = 0.031).
Median heart rate before the cooling cycle was 80.0 bpm (Q1: 62.8 bpm; Q3: 91.8 bpm), afterwards it decreased to 77.5 bpm (Q1: 66.5 bpm; Q3: 80.5 bpm), yielding no significant difference (p = 0.406).
The pre-cycle assessment showed no significant difference in median HR (p = 0.063). The difference after the cycles was significant (p = 0.031).
The pre-cycle assessment showed no significant difference in median HR (p = 0.500). The difference after the cycles was not significant (p = 0.406).
The pre-cycle assessment showed no significant difference in median HR (p-value = 0.313). The difference after the cycles was significant (p = 0.031).
Systolic and diastolic BP were measured pre-cycle and post-cycle. No significant differences either before and after or between the cycles were shown.
Concentration performance indicator (CPI) and total number of errors (TNE) of each subject were determined pre-cycle and post-cycles. Test results are summarized in Fig. 5.
Median CPI and TNE before base cycle were 255.0 (Q1: 168.5; Q3: 273.0) and 20.3 (Q1: 12.4; Q3: 77.7), respectively. Afterwards, they were 255.0 (Q1: 172.3; Q3: 270.8) and 20.8 (Q1: 13.5; Q3: 77.2), respectively, indicating no significant difference (CPI: p = 0.594; TNE: p = 0.625).
Median CPI and TNE before PPE cycle were 254.5 (Q1: 161.8; Q3: 273.5) and 21.2 (Q1: 11.5; Q3: 83.4), respectively. Afterwards, they were 179.0 (Q1: 152.0; Q3: 212.8) and 39.6 (Q1: 29.0; Q3: 79.7), respectively, indicating a significant difference for CPI (p = 0.031), but not TNE (p = 0.219).
Median CPI and TNE before cooling cycle were 255.5 (Q1: 164.5; Q3: 275.3) and 20.5 (Q1: 11.5; Q3: 81.7), respectively. Afterwards, they were 259.0 (Q1: 165.5; Q3: 278.3) and 18.6 (Q1: 10.7; Q3: 80.7), respectively, indicating no significant difference for CPI (p = 0.063), but for TNE (p = 0.031).
Pre-cycle assessments showed no significant differences between CPI (p = 0.344) or TNE (p = 0.563). After the cycles, CPI yielded a significant difference (p = 0.031), but not TNE (p = 0.063).
Pre-cycle assessments showed no significant differences for CPI (p = 0.813) or TNE (p = 0.563). Afterwards no significant differences were seen either (CPI: p = 0.750, TNE: p = 0.688).
Pre-cycle assessments showed no significant difference between CPI (p = 0.656) or TNE (p = 0.594). Afterwards, the difference between CPI was significant (p = 0.031), but not between TNE (p-value = 0.156).
There is increasing concern about diverse stressors affecting physicians during various scenarios . Thermal stress as caused by PPE is one well-documented factor decrementing vigilance and endurance [1, 10] and directly influencing human performance, whose flawless functioning is of utmost importance during exceptional situations such as the current COVID-19 pandemic. We could show that even relatively mild thermal stress negatively affects concentration, while increasing physiological stress levels. Parameters such as HR , BP or BT served as variables indicating stress levels, subjects were experiencing. Homogeneous values before and after base cycle proved that the performed tasks themselves do not cause an elevated physical stress level. After PPE cycle, significantly increased BT (p = 0.031) and HR (p = 0.031) were observed, suggesting considerable high physical (thermal) stress compared to pre-cycle levels.
Several studies investigated effects of heat on cognition [18, 19]. Our study could confirm the described correlation between increased temperatures and decrements in concentration and performance, since lower attention test results were produced after PPE cycle. Compared to the pre-cycle, CPI significantly decreased afterwards (p = 0.031). PPE may not only constitute an intense burden, but ultimately jeopardize adequate patient care due to its negative impact on the users’ performance. To ensure proper medical care of COVID-19 patients while providing highest possible comfort for medical personnel, achieving a balance between sufficient protection and reduced heat strain is of utmost importance. In order to achieve this goal, several aspects need to be considered. More breathable materials lead to higher user satisfaction as shown by Verbeek et al. . Heat generation of less breathable materials could be a contributing factor for this, which is why two different suits differing in thickness were tested in our study. No significant difference regarding their heat production potential in the study period, neither after the PPE cycle (p = 0.500) nor after the cooling cycle (p = 0.100) was shown.
Cooling-wear may be an effective means to reduce thermal stress caused by PPE. Subjects wearing cooling-wear beneath scrubs and PPE were significantly less affected. This suggests the ability of cooling-wear to reduce the physiological stress level caused by increased temperatures. Physiological parameters after the cooling cycle almost reached pre-cycle levels. Not only BT (p = 0.031) but also ST (p = 0.031) was significantly lower after cooling compared to after PPE cycle. An increase of BT within cooling cycle was seen (24.50–26.00 °C); however, less pronounced than in PPE cycle (24.50–26.95 °C). Hereby, a counteracting function of cooling-wear against heat production below PPE is suggested. Even after 1h of activity, a visible cooling effect was revealed by thermal imaging (Fig. 3).
Furthermore, positive effects on concentration and attention were observed in subjects wearing cooling wear. CPI was significantly higher after cooling than after PPE cycle (p = 0.031), while a lower TNE, although not significant (p = 0.156), was observed. Ultimately, an improvement of cognitive performance in warm environments is supposedly possible with cooling-wear.
The small sample size may lead to not fully representative and transferable results; however, this novel invention might be able to bridge the gap between proper medical care without contagion and adequate comfort for medical personnel. Particularly, caregivers of COVID-19 patients may profit from further development and in-depth investigation of cooling strategies. Further studies are necessary to achieve the full potential of cooling-wear in reducing thermal stress.
This study has several limitations: We aimed to investigate the burden of PPE and the advantages of novel cooling strategies for use in the medical field. Due to the small sample size, results may not be representative and transferable. Further studies are necessary to reach the full potential of cooling-wear in reducing thermal stress. While the study set-up was designed to reduce the possible bias caused by fatigue and repetition, individual performance levels (cognitive and physical) are dependent on personal form of the day. This is for example reflected in higher pre-cycle HR, even though not statistically significant (pre-cooling: 80.0 bpm vs. pre-PPE: 73.5 bpm). Analysis of BP values revealed no significant differences. The values of each subject, however, varied strongly, especially post-PPE. This divergence indicates individual reactions of the circulatory system to thermal stress in each subject. Consequently, a bias by individual factors, such as daily activity or autonomic nerve tone, cannot be ruled out. Ultimately, there is a great demand for strategies to withstand thermal stress and reduce discomfort caused by PPE and to improve working conditions during these challenging times.
Decrements in vigilance, performance and endurance are well-documented effects of thermal stress and have been confirmed in this study. Thermal stress due to PPE used in the management of COVID-19 patients leads to increased BT and HR. Simultaneously, the concentration capacity decreases and the error-proneness increases. These results highlight the burden of PPE, medical personnel have to bear during the current COVID-19 pandemic. As an opportunity to withstand thermal stress and therefore improve medical care, cooling strategies are useful in many aspects. Most physiological parameters measured after cooling cycle almost reached pre-cycle levels, indicating lower physiological stress levels. Due to the need of the balance between sufficient protection and reduced heat strain, cooling-wear serves as promising opportunity to counteract encumbering situations with heat exposure.
Based on the promising results obtained from this project, cooling strategies may be used as important tool in medical sectors prospectively. Further studies are necessary to achieve the full potential of this newly developed cooling-wear.
The cooling-wear was provided by QRSKIN GmbH (Würzburg, Germany) free of charge.
H. Luze, S.P. Nischwitz, P. Kotzbeck, J. Fink, J.C. J. Holzer, D. Popp, and L.-P. Kamolz declare that they have no competing interests.
All procedures performed in studies involving human participants or on human tissue were in accordance with the ethical standards of the institutional and/or national research committee and with the 1975 Helsinki declaration and its later amendments or comparable ethical standards. This research was done without patient involvement. Patients were not invited to comment on the study design and were not consulted to develop patient-relevant outcomes or interpret the results. Patients were not invited to contribute to the writing or editing of this document for readability or accuracy. The study design and protocol were approved by the ethical review committee of the Medical University of Graz (EK: 1318/2019). Written informed consent was obtained from study participants prior to the study start.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.